Globeflex Capital’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Globeflex Capital's URGN Position: Q3 2026 in Review
Globeflex Capital opened a new position in UroGen Pharma (URGN) in Q3 2026: 3,552 shares worth $144K. The stake represents 0.02% of the portfolio and ranks #339 among its holdings. This is a return to the name: Globeflex Capital previously reported a position in URGN as recently as Q4 2022.
Globeflex Capital first reported a position in URGN in Q4 2022 and has held it in 2 quarters since. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Globeflex Capital held 3,552 shares of UroGen Pharma worth $144K as of Q3 2026.
- UroGen Pharma was a new Globeflex Capital position in Q3 2026.
- UroGen Pharma made up 0.02% of Globeflex Capital's portfolio in Q3 2026, its #339 holding.
- Globeflex Capital first reported a position in UroGen Pharma in Q4 2022 and has held it in 2 quarters since.
- 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Globeflex Capital's 13F filing for Q3 2026, filed 16 Nov 2026.